Beliefs about the usefulness of initiatives to reduce opioid prescribing in clinical practice and autonomy in prescribing may be important considerations in driving compliance.

This article describes the need for real-time information about high-risk psychoactive medicines, and the development of SafeScript.

The need for medicinal and procedural treatment for many conditions can be reduced if proficiency in exercise prescription is developed.

This editorial highlights and champions the success of general practice in enhancing the lives of all Australians and supporting those in need.

This review summarises the evolving status of melanoma care, emphasising when to refer patients to medical oncologists as part of the multidisciplinary team.

A Caucasian woman aged 49 years presented with a three-day history of a widespread maculopapular erythematous eruption involving the torso, limbs and acral surfaces.

A man aged 62 years who worked as school cleaner presented with concerns of a blue-grey colouration to all his nails.

A Caucasian woman aged 65 years presented with painful mouth ulcers, conjunctivitis and a new blistering eruption on the central chest and forearm 10 days after commencing topical imiquimod 5% cream.

Paracetamol allergy is uncommon and, as a result, may be overlooked as a cause for immediate hypersensitivity, which can lead to a significant delay in diagnosis.

This paper provides a summary of the evidence supporting the use of PCSK9 inhibitors and siRNA, with relevant recommendations from consensus guidelines.

The aim of this paper is to provide an update on advances in cardiac implantable electronic devices technology and how this applies to managing patients.

The aim of achieving equitable access to bulk billing for those living in rural and regional Victoria has not yet been met, and may be under increasing pressure.

Two patients presented with a history of widespread itch with blisters (bullae).

As patients on methadone age, their likelihood for developing diseases requiring new medications places them at risk of life-threatening drug interactions.

Pharmaceutical industry interactions with professional medical associations have come under scrutiny, yet industry ties among the leadership of these associations are often overlooked.